New cancer clinical trial: Prevention of Cardiac Dysfunction During Breast Cancer Therapy

Published on: November 30, 2018 at 12:00PM
Conditions:   Breast Cancer Female;   Heart Failure
Intervention:   Drug: LCZ696
Sponsors:   Torbjorn Omland;   University Hospital, Akershus;   Oslo University Hospital;   University Hospital of North Norway;   St. Olavs Hospital;   Helse Stavanger HF;   KLINBEFORSK;   Norwegian Cancer Society;   Novartis
Not yet recruiting
https://ift.tt/2QwNMRC